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Human γδT cells expressing the Vγ9Vδ2 T cell receptor can induce maturation of dendritic
cells (DC) into antigen-presenting cells (APC) and B cells into antibody-secreting plasma
cells. Since B cells are capable of presenting antigens toT cells, we investigated if Vγ9Vδ2
T cells can influence antigen-presentation by these cells. We report that Vγ9Vδ2 T cells
induced expression of CD86, HLA-DR, and CD40 by B cells and stimulated the release of
IL-4, IL-6,TNF-α, and IgG, IgA, and IgM. Vγ9Vδ2T cells also augmented the ability of B cells
to stimulate proliferation but not IFN-γ or IL-4 release by alloreactive T cells. In contrast,
Vγ9Vδ2T cells induced expression of CD86 and HLA-DR and the release of IFN-γ, IL-6, and
TNF-α by DC and these DC stimulated proliferation and IFN-γ production by conventional
T cells. Furthermore, CD86, TNF-α, IFN-γ, and cell contact were found to be important in
DC activation by Vγ9Vδ2T cells but not in the activation of B cells.These data suggest that
Vγ9Vδ2 T cells can induce maturation of B cells and DC into APC, but while they prime DC
to stimulate T helper 1 (TH1) responses, they drive maturation of B cells into APC that can
stimulate different T cell responses. Thus, Vγ9Vδ2 T cells can control different arms of the
immune system through selective activation of B cells and DC in vitro, which may have
important applications in immunotherapy and for vaccine adjuvants.
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INTRODUCTION
T cells expressing the Vγ9Vδ2 T cell receptor (TCR) comprise the
most abundant γδ T cell subset in human blood, where they typi-
cally account for 1–5% of T cells in healthy adults (1–4). In many
microbial infections,Vγ9Vδ2 T cells dramatically expand,reaching
>50% of all T cells at infected sites (5), thus indicating their impor-
tance in antimicrobial immunity and their potential for diagnostic
and therapeutic use. The Vγ9Vδ2 TCR recognizes a variety of
low molecular weight pyrophosphate intermediates of isoprenoid
biosynthesis (phosphoantigens), but the most potent phospho-
antigen known is (E)-4-hydroxy-3-methyl-but-2-enyl pyrophos-
phate (HMB-PP), an intermediate of the non-mevalonate pathway
that is found in the majority of Gram-negative bacteria, some
Gram-positive species and some parasites, such as Plasmodium fal-
ciparum and Toxoplasma gondii (1, 6). Recently, butyrophilin 3A
(BTN3A/CD277) was shown to bind to phosphoantigens within
cells, resulting in activation of Vγ9Vδ2 T cells (7, 8). HMB-PP can
be used to induce in vitro expansion and activation of Vγ9Vδ2 T
cells (9, 10). Activated Vγ9Vδ2 T cells exhibit a range of effector
functions including direct cytotoxicity of infected and tumor cells,
the induction of inflammatory and immunoregulatory processes
and promotion of the survival, differentiation and activation of
monocytes, neutrophils, dendritic cells (DC), αβ T cells, and B
cells (1–4).
Recent studies have provided evidence that Vγ9Vδ2 T cells can
bridge innate and adaptive immune responses by promoting the
differentiation of a number of cell types into antigen-presenting
cells (APC). DC are the most potent professional APC. They exist
in peripheral tissues as specialized cells for pathogen recognition
and uptake by phagocytosis, endocytosis, and pinocytosis, which
results in their upregulated expression of antigen-presenting and
co-stimulatory molecules, secretion of cytokines, and migration to
lymphoid organs where they present antigen to naïve T cells (11,
12). Vγ9Vδ2 T cells, alone and in synergy with pathogen products,
can induce differentiation of DC into immunogenic APC that
express co-stimulatory markers, produce cytokines and stimulate
T cells (10, 13–17). Furthermore, HMB-PP-stimulated Vγ9Vδ2 T
cells are also capable of promoting survival and differentiation of
monocytes into inflammatory DC (18, 19). Vγ9Vδ2 T cells are also
capable of inducing recruitment, activation, and survival of neu-
trophils (20, 21) and a recent study has shown that neutrophils
exposed to Vγ9Vδ2 T cells acquire the ability to present micro-
bial antigens to CD4+ T cells and to cross-present endogenous
antigens to CD8+ T cells (22).
B cells are also capable of presenting antigens to T cells (23) and
secreting cytokines that activate and regulate adaptive immune
responses (24). A number of studies have demonstrated that
Vγ9Vδ2 T cells can induce differentiation of B cells into antibody-
producing plasma cells (25–28). They can be found in germinal
centers, can acquire features of follicular helper T cells and can
induce the production and affinity maturation of class-switched
antibodies. However, it is not known if Vγ9Vδ2 T cells contribute
to antigen-presentation and cytokine secretion by B cells. The aim
of the present study was to investigate the ability of Vγ9Vδ2 T cells
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to induce differentiation, cytokine secretion, antibody production,
and T cell allostimulation by B cells and how this compares to
the adjuvant effect of Vγ9Vδ2 T cells for DC. We also exam-
ined the requirements for cell contact, co-stimulatory molecule,
and cytokine receptor engagement between Vγ9Vδ2 T cells and B
cells or DC for their reciprocal stimulatory activities. Our results
show that Vγ9Vδ2 T cells induce maturation of both DC and B
cells into APC that express co-stimulatory molecules and produce
cytokines, and that these mature DC and B cells are capable of
inducing alloreactive T cell proliferation. In addition, Vγ9Vδ2 T
cell-stimulated B cells secrete antibodies. However, we show that
Vγ9Vδ2 T cell-matured DC and B cells have different cytokine
profiles and distinct stimulatory capacities for T cells and are medi-
ated by different molecular interactions. Thus, Vγ9Vδ2 T cells can
control different effector arms of the immune system through
interactions with DC and B cells in vitro.
MATERIALS AND METHODS
DONORS
Peripheral blood mononuclear cells were prepared from healthy
human buffy coat packs obtained from the Irish Blood Transfusion
Service (IBTS, St. James’s Hospital, Dublin, Ireland) by standard
density gradient centrifugation over Lymphoprep™(Nycomed
Pharma, Oslo, Norway). The IBTS provides pro bono blood com-
ponents to Irish third level educational facilities or health care
facilities for the purposes of research and education. This blood
is from voluntary, anonymous, non-remunerated donors donated
primarily for therapeutic application to patients.
IN VITRO Vδ2 T CELL EXPANSION
γδ T cells were enriched from peripheral blood mononuclear cells
(PBMC) by positively selecting γδ TCR+ cells using a magnetic
Microbead cell sorting kit (Miltenyi Biotec, Bergisch-Gladbach,
Germany). Vγ9Vδ2 T cells were expanded in 24-well plates by
stimulating with 10 nM HMB-PP (kindly provided by Dr. Hassan
Jomaa and Dr. Armin Reichenberg) and culturing them in com-
plete RPMI (cRPMI) medium (RPMI 1640 with Glutamax con-
taining 10% heat inactivated fetal calf serum, 50 U/ml penicillin,
50 mg/ml streptomycin, 2µg/ml fungizone, and 25mM HEPES
buffer, Gibco-BRL, Paisley, UK) supplemented with 50 IU/ml IL-2
(Peprotech, New Jersey, USA or Miltenyi Biotec). The medium was
changed every 3–4 days by replacing with fresh IL-2-supplemented
cRPMI. The cells were harvested on days 14–28 and used for co-
culture with DC or B cells. We previously found that virtually all
Vδ2+ T cells express the Vγ9 chain. Therefore,Vγ9Vδ2 T cells were
subsequently identified by a Vδ2 monoclonal Ab (mAb) and are
referred to as Vδ2 T cells hereafter (10). Cell purities were deter-
mined by staining with mAb against CD3 and Vδ2 and analyzing
by flow cytometry.
B CELL ISOLATION
B cells were obtained from human PBMC by positive selection
magnetic bead cell sorting (Miltenyi Biotec) of CD19+ lympho-
cytes or by negative selection magnetic bead cell sorting of CD19−
lymphocytes (Stemcell Technologies, Canada). The B cells were
suspended in cRPMI and used fresh for co-culture with Vδ2 T
cells. Purity was determined by staining the cells with anti-CD19
and anti-CD20 mAb and analysis by flow cytometry.
DENDRITIC CELL PREPARATION
Monocyte-derived DC were obtained from human PBMC by pos-
itively selecting CD14+ cells (Miltenyi Biotec). The monocytes
were induced to differentiate into immature DC by culturing
them in DC medium (RPMI 1640 supplemented with 10% heat
inactivated, filtered low-endotoxin HyClone fetal calf serum, 1%
penicillin-streptomycin, 1% fungizone, 1% L-glutamine, 0.1% β-
mercaptoethanol, 1% sodium pyruvate, 1% non-essential amino
acid mixture, 1% essential amino acid mixture, and 2% HEPES;
Gibco-BRL; Logan, UT, USA) containing IL-4 (70 ng/ml) and
GM-CSF (50 ng/ml) (Immunotools, Friesoythe, Germany). After
3 days, medium was replaced with fresh DC medium containing
IL-4 and GM-CSF. On day 6, immature DC were harvested and
used for co-culture with Vδ2 T cells.
ANTIBODIES AND FLOW CYTOMETRY
Fluorochrome-conjugated human mAb specific for CD3, CD11c,
CD14, CD19, CD20, CD40, CD80, CD86, HLA-DR, IFN-γ, IL-4,
IL-6, IL-10, IL-12p40, IL-13, TNF-α, and Vδ2 were obtained from
Biolegend (San Diego, CA, USA), Immunotools or eBioscience
(Hatfield, UK). Fixable viability dye eFluor 506 (eBioscience) was
used to determine cell viability. Staining was carried out in PBA
buffer (phosphate-buffered saline containing 1% bovine serum
albumin and 0.02% sodium azide; Gibco-BRL; Sigma-Aldrich,
Ireland) and analyzed using CyAn ADP (Beckman Coulter, High
Wycombe, UK) or FACS Canto-II (Becton Dickinson, USA) flow
cytometers and FlowJo software (Treestar, Ashland, OR, USA)
using fluorescence-minus-one controls. Flow cytometry was used
to look at cell surface phenotypes, intracellular cytokines, antibody
production, co-stimulatory marker expression, and alloreactive T
cell proliferation.
ANALYSIS OF CO-STIMULATORY MARKER EXPRESSION BY DC AND B
CELLS
Vδ2 T cells were cultured with either B cells or DC in equal
numbers in the presence or absence of HMB-PP (10 nM) for
72 or 24 h in cRPMI, respectively. The cells were stained for
expression of CD11c (DC) or CD19 (B cells) and markers of
antigen-presentation CD40, CD80, CD86, and HLA-DR. Surface
expression of these markers was compared by mean fluorescence
intensity (MFI) readings obtained using flow cytometry.
ANALYSIS OF CYTOKINE RELEASE FROM CO-CULTURES
Vδ2 T cells were cultured with either B cells or DC in equal
numbers in the presence or absence of HMB-PP for 72 or 24 h,
respectively. The supernatants were then harvested and assayed for
levels of IFN-γ, IL-4, IL-6, IL-10, IL-12p70, and TNF-α by enzyme-
linked immunosorbent assay (ELISA) using R&D Systems DuoSet
kits (Abingdon, UK).
ANALYSIS OF INTRACELLULAR CYTOKINE PRODUCTION
Vδ2 T cells were cultured with either B cells or DC at 1:1 ratios in
the presence or absence of HMB-PP for 24 h and then treated with
monensin (10µl/ml, Biolegend) overnight. The cells were then
stained for cell surface expression of CD3 and Vδ2 (Vδ2 T cells),
CD19 (B cells), or CD11c (DC). The cells were then fixed and
permeabilized and stained for intracellular expression of IFN-γ,
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IL-4, IL-6, IL-10, IL-12p40, IL-13, and TNF-α for analysis by flow
cytometry.
MEASUREMENT OF ANTIBODY PRODUCTION BY B CELLS
Vδ2 T cells were cultured with B cells at 1:1 ratios in the pres-
ence or absence of HMB-PP (10 nM) for 7 days. The supernatants
were harvested and analyzed using immunoglobulin cytometric
bead array kits (Becton Dickinson) for IgA, IgM, IgE, and total
IgG levels.
BLOCKING EXPERIMENTS
Vδ2 T cells were cultured with either DC or B cells in equal num-
bers in the presence or absence of HMB-PP and low-endotoxin,
azide-free functional grade blocking antibodies against CD86,
CD40L, IFN-γ and IFN-γR, IL-4 and IL-4R, or TNF-α or isotype
control mAbs for 24 h. Similar cultures were set up in transwell
plates to prevent cell contact. The effects of blocking on DC and
B cell phenotypes, cytokine expression and release and antibody
production were determined as described above.
ALLOREACTIVE T CELL PROLIFERATION
Vδ2 T cells were cultured with either B cells or DC in equal num-
bers in the presence or absence of HMB-PP for 24 h. γδ− PBMC
were enriched for CD3+ cells using a magnetic bead cell sorting
kit (Miltenyi Biotec) and stained using a CellTrace™ kit (Invit-
rogen, CA, USA). The CellTrace-labeled resting alloreactive αβ T
cells were added to the overnight culture at ratios of 10:1 or 1:1
and cultured for 6 days before analysis of CellTrace dye dilution of
CD3+ T cells by flow cytometry. Phytohemagglutinin-P (Sigma-
Aldrich)-stimulated αβ T cells cultured with IL-2 and irradiated
PBMCs were used as positive controls. Similar co-cultures, except
using unlabeled alloreactive αβ T cells, were incubated for 3 days
to look for expression of intracellular cytokines by alloreactive T
cells. The supernatants harvested on day 3 were assayed for IL-2,
IL-4, IL-10, and IFN-γ secretion by ELISA.
STATISTICAL ANALYSIS
GraphPad Prism 5.0 (San Diego, CA, USA) was used to carry out
paired and unpaired t -tests to compare the means between groups.
P values of <0.05 were considered statistically significant.
RESULTS
Vδ2 T CELLS INDUCE APC MARKER EXPRESSION BY DC AND B CELLS
We initially investigated if Vδ2 T cells can induce differentiation of
B cells into cells with phenotypes of APC. Therefore, we examined
the expression of CD40, CD86, and HLA-DR by B cells or DC
after co-culture with non-stimulated or HMB-PP-activated Vδ2 T
cells. Vδ2 T cells induced an increase in CD86 (Figure 1A) and
HLA-DR (Figure 1C), but not CD40 (Figure S1A in Supplemen-
tary Material) expression by DC after 24 h and CD86 (Figure 1B),
HLA-DR (Figure 1D) and CD40 (Figure S1B in Supplementary
Material) expression by B cells after 72 h. CD86 expression was
also upregulated on B cells after 24 h. To investigate which mol-
ecules are involved in DC and B cell activation by Vδ2 T cells or
whether it is cell contact dependent, the same co-cultures were
set up in the presence of HMB-PP-activated Vδ2 T cells and one
of several blocking antibodies or transwell inserts which prevent
FIGURE 1 | Vδ2T cells induce the expression of APC markers by
dendritic cells (DC) and B cells (BC).
(Continued)
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FIGURE 1 | Continued
Monocyte-derived DC or enriched peripheral blood B cells were co-cultured
for 24 or 72 h with HMB-PP-expanded human Vδ2 T cells in the absence or
presence of HMB-PP (denoted H). Cells were then stained using mAb
specific for CD11c or CD19 and CD86 and HLA-DR and analyzed by flow
cytometry. Left panels show average (±SEM) mean fluorescence
intensities (MFI) of staining for CD86 expression by (A) DC (n=11) and
(B) B cells (n=12) and HLA-DR expression by (C) DC (n=9) and (D) B cells
(n= 7). Right panels show average (±SEM) MFI of staining for CD86 or
HLA-DR by DC or B cells after co-culturing them with Vδ2 T cells in the
presence of HMB-PP in the absence (control) or presence of blocking mAbs
specific for CD86, CD40L, TNF-α, IFN-γ+ IFN-γR, IL-4+ IL-4R or with the DC
or B cells separated from Vδ2 T cells using transwell inserts (n=5 for DC
treatments and n=3 for BC treatments). *p<0.05, **p<0.01 using a
paired t -test, compared to DC or BC alone (left panels) or compared to BC
control (right panels) and unpaired t -test compared to DC control (right
panels) except where indicated by horizontal lines.
cell contact between the different cell types in the co-cultures. The
results show that cell contact is important for CD86 expression by
DC (Figure 1A), while CD86, TNF-α, and IFN-γ are important for
HLA-DR expression by DC (Figure 1C). In contrast, CD40L and
cell contact are important for HLA-DR expression (Figure 1D)
but not CD40 expression (Figure S1B in Supplementary Material)
by Vδ2-stimulated B cells.
Vδ2 T CELLS INDUCE DISTINCT CYTOKINE EXPRESSION BY DC AND B
CELLS
To further characterize the influence of Vδ2 T cells on DC and B
cell activation, we examined the same co-cultures for intracellu-
lar cytokine expression. The co-cultures, as described above, were
treated with monensin for 16 h and the DC or B cells were analyzed
for intracellular IFN-γ, IL-4 (Figures 2A,B), and TNF-α (Figure
S2 in Supplementary Material) expression by flow cytometry. Vδ2
T cells induced IFN-γ expression by DC (Figure 2C) but not B
cells and IL-4 expression by B cells (Figure 2D) but not DC. In
contrast, Vδ2 T cells induced TNF-α expression by both DC and B
cells (Figure S2 in Supplementary Material). The blocking studies
revealed that CD86 and IFN-γ are important for IFN-γ expres-
sion by DC (Figure 2C), but not for cytokine production by B
cells (Figure 2D).
Vδ2 T CELLS INDUCE PRO- AND ANTI-INFLAMMATORY CYTOKINE
SECRETION FROM DC AND B CELL CO-CULTURES
While the flow cytometric cytokine assay revealed the percentage
of cells expressing cytokines, we wanted to quantify the levels of
cytokine production from the co-cultures. After 24 h co-culture of
Vδ2 T cells and DC or B cells, supernatants were analyzed for lev-
els of IFN-γ, TNF-α, IL-4, IL-6, IL-10, and IL-12 by ELISA. Since
the cellular source of the cytokines produced cannot be identi-
fied, we also examined cytokine production by Vδ2 T cells alone.
We found that Vδ2-DC co-cultures produced IFN-γ (Figure 3A),
TNF-α (not shown),and IL-6 (Figure S3A in Supplementary Mate-
rial) but not IL-4 (Figure 3C), IL-10, or IL-12 (Figure S3A in
Supplementary Material) after 24 h. In contrast, Vδ2-B cell co-
cultures produced TNF-α and IL-6 but did not augment IFN-γ
(Figure 3B), IL-4 (Figure 3D), IL-10, or IL-12 (Figure S3B in
Supplementary Material) production compared with Vδ2 T cells
cultured alone. IFN-γ production by HMB-PP-activated Vδ2 T
cells was also observed by flow cytometry (data not shown). None
of the molecules tested in the blocking studies,nor cell contact were
found to be important for cytokine secretion by these co-cultures.
However, surprisingly, blocking of CD86 resulted in augmented
IFN-γ secretion after co-culture with Vδ2 T cells.
Vδ2 T CELLS INDUCE ANTIBODY PRODUCTION BY B CELLS
Previous studies have shown that a subset of Vδ2 T cells can provide
help for antibody production by B cells and that it was mediated
by CD40L, ICOS, and IL-10 (28). To investigate whether Vδ2 T
cells can induce immunoglobulin production by fresh peripheral
B cells in vitro,Vδ2 T cells were cultured with B cells for 7 days, and
the supernatants were analyzed for total IgG, IgA, IgM, and IgE by
a flow cytometric bead array. Vδ2 T cells induced IgG (Figure 4A),
IgA (Figure 4B), IgM (Figure 4C) but not IgE (Figure 4D) produc-
tion by B cells, while HMB-PP-activated Vδ2 T cells prevented IgA
(Figure 4B) and IgM (Figure 4C) production. The blocking stud-
ies revealed that the cytokines and co-stimulatory markers exam-
ined and cell contact, do not play a part in antibody production
by B cells.
Vδ2-MATURED DC AND B CELLS STIMULATE PROLIFERATION OF
RESTING ALLOGENEIC T CELLS
We investigated whether Vδ2 T cell-matured DC and B cells can
induce activation and proliferation of resting αβ T cells. Vδ2 T
cell-matured DC or B cells were cultured with 10 times as many
CellTrace-labeled resting allogeneic αβ T cells for 6 days and dye
dilution due to cell proliferation was examined by flow cytometry
(Figures 5A,B). The co-cultures showed that both DC (Figure 5C)
and B cells (Figure 5D) induced activation and proliferation of
resting T cells after co-culture with Vδ2 T cells. Similar 3 day
co-cultures were set up for analysis of cytokine secretion. ELISA
showed that Vδ2 T cell-matured DC induced IFN-γ but not IL-4
production by T cells, whereas Vδ2 T cell-matured B cells did not
stimulate cytokine production by T cells (Figures 5C,D; Figure S5
in Supplementary Material).
ALLOGENEIC AND AUTOLOGOUS Vδ2 T CELLS EQUALLY ACTIVATE DC
AND B CELLS
The experiments described above indicate that Vδ2 T cells can dif-
ferentially induce MHC and co-stimulatory molecule expression,
cytokine production, and T cell allostimulation by allogeneic DC
and B cells. We also investigated if the same outcomes could be
observed when Vδ2 T cells were cultured with autologous DC or B
cells. Figure S4 in Supplementary Material shows that Vδ2 T cells
could equally induce CD86 expression (Figure S4A in Supplemen-
tary Material) and IL-12 secretion (Figure S4B in Supplementary
Material) by autologous and allogeneic DC, and CD86 expres-
sion (Figure S4C in Supplementary Material) and IL-4 secretion
(Figure S4D in Supplementary Material) by autologous and allo-
geneic B cells. Thus it appears that allogeneic Vδ2 T cells can
be substituted for autologous Vδ2 cells as adjuvants for DC or
B cells.
DISCUSSION
Vγ9Vδ2 T cells exhibit a myriad of effector functions in innate
and adaptive immunity. They can kill infected, tumor, and stressed
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FIGURE 2 | Vδ2T cells induce distinct cytokine profiles by DC and B cells.
DC or B cells were co-cultured with HMB-PP-expanded human Vδ2 T cells in
the absence or presence of HMB-PP (denoted H) for 24 h. The cultures were
then treated with monensin for a further 16 h and stained for cell surface
expression of CD11c or CD19 and CD3 and Vδ2 and intracellular expression of
IFN-γ or IL-4 and analyzed by flow cytometry. (A,B) Representative flow
cytometric dot plots showing IFN-γ and IL-4 expression by gated CD11c+ cells
(DC) and CD19+ cells (BC), respectively. (C,D) Left and center panels show
mean (±SEM) percentages of (C) DC (n=10) and (D) BC (n=10) that express
IFN-γ and IL-4, respectively. Right panels show mean (±SEM) percentages of
(C) DC and (D) BC expressing IFN-γ and IL-4, respectively, after co-culturing
them with Vδ2 T cells in the presence of HMB-PP in the absence (control) or
presence of blocking mAbs specific for CD86, CD40L, TNF-α, IFN-γ+ IFN-γR,
IL-4+ IL-4R or with the DC (n= 5), or BC (n=3) separated from Vδ2 T cells
using transwell inserts. *p<0.05 using a paired t -test, compared to DC or BC
alone (left panels) or compared to BC control (right panels) and unpaired t -test
compared to DC control (right panels) except where indicated by horizontal
lines.
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FIGURE 3 | Co-cultures of Vδ2T cells and DC or B cells have distinct
cytokine secretion profiles.
(Continued)
FIGURE 3 | Continued
DC or B cells were co-cultured with HMB-PP-expanded human Vδ2 T cells in
the absence or presence of HMB-PP (denoted H). After 24 h (for DC) or 72 h
(for B cells), supernatants were harvested and analyzed for IFN-γ and IL-4 by
ELISA. Left panels show mean (±SEM) concentration of IFN-γ in (A) DC
(n=3) and (B) BC (n=3) co-cultures and IL-4 in (C) DC (n= 3) and (D) BC
(n=6) co-cultures. Right panels show average (±SEM) concentration of
IFN-γ and IL-4 from the DC and B cell co-cultures in the presence of
HMB-PP in the absence (control) or presence of blocking mAb specific for
CD86, CD40L, TNF-α, IFN-γ+ IFN-γR, IL-4+ IL-4R or with the DC (n= 5), or
B cells (n=3) separated from Vδ2 T cells using transwell inserts. *p<0.05,
**p<0.01 Using a paired t -test, compared to DC or BC alone (left panels)
or compared to BC control (right panels) and unpaired t -test compared to
DC control (right panels) except where indicated by horizontal lines.
target cells, promote inflammation and wound healing, promote
the survival, differentiation and activation of monocytes, neu-
trophils, and DC, provide B cell help for antibody production
and prime CD4+ and CD8+ T cells (1–4). Vγ9Vδ2 T cells can
also link innate and adaptive immune responses by promoting
differentiation of different types of cells into APC that are capa-
ble of initiating antigen-specific T cell responses and long-term
immunological memory (10, 13–19, 22, 29). These findings impli-
cate Vγ9Vδ2 T cells as candidate targets for development of novel
therapies and vaccines.
The findings in the present study confirm previous reports that
Vγ9Vδ2 T cells can induce maturation, MHC and co-stimulatory
receptor expression, and TH1 cytokine production by DC (10,
13–17) and further show that these matured DC can stimulate
proliferation and TH1 cytokine production by alloreactive αβ T
cells. We found that Vδ2-DC co-cultures secreted IFN-γ, TNF-
α, and IL-6 but not IL-4 and IL-10 after 24 h. While Vδ2 T cells
were not potent inducers of IL-12 production by DC, they exhib-
ited a strong synergistic effect with TLR ligands, such as LPS in
inducing IL-12 release. Importantly, DC matured with Vδ2 T cells
could stimulate proliferation and IFN-γ production by resting
alloreactive T cells in vitro, suggesting that these APC also prime
antigen-specific TH1 responses. Although we did not test if Vδ2
T cell-matured DC could present specific antigen to T cells, their
ability to stimulate alloreactive T cells to a greater degree than DC
that had not been cultured with Vδ2 T cells, suggests that Vδ2 T
cells are promoting differentiation of DC into APC.
Previous studies have demonstrated that Vγ9Vδ2 T cells can
induce maturation of B cells into antibody-secreting plasma cells
(25–28), suggesting that they can promote humoral immune
responses in vivo. We showed that HMB-PP-stimulated Vδ2 T cells
can stimulate the production of IgG, IgM, and IgA but not IgE by B
cells in vitro and that HMB-PP prevents IgM and IgA production.
We also examined the phenotypic changes to B cells that occur in
response to co-culturing them with Vδ2 T cells and found that,
like for DC, B cells upregulated HLA-DR, CD40, and CD86, sug-
gesting that Vδ2 T cells can drive maturation of B cells into APC.
However, analysis of cytokine production revealed that Vδ2-B cell
co-cultures could produce TNF-α, IL-6, and IL-4 but not IFN-γ
or IL-12. Thus Vδ2-matured DC and B cells have distinct cytokine
profiles, with B cells lacking the TH1-promoting cytokine bias
seen for DC. Analysis of the capacity of Vδ2 T cell-matured B cells
to stimulate alloreactive T cells indicated that they could induce
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FIGURE 4 | Vδ2T cells induce antibody production by B cells.
(Continued)
FIGURE 4 | Continued
B cells were co-cultured with HMB-PP-expanded human Vδ2 T cells in the
absence or presence of HMB-PP (denoted H). After 7 days the supernatants
were harvested and analyzed for IgA, IgM, IgE, and total IgG levels by
cytometric bead array and flow cytometry. Left panels show average mean
(±SEM) MFI of staining for (A) IgG (n=5), (B) IgA (n=8), (C) IgM (n=7),
and (D) IgE (n=2). Right panels show average (±SEM) MFI intensities of
IgG, IgA, IgM, and IgE of B cells after co-culturing them with Vδ2 T cells in
the presence of HMB-PP in the absence (control) or presence of blocking
mAbs specific for CD86, CD40L, TNF-α, IFN-γ+ IFN-γR, IL-4+ IL-4R, or with
the B cells separated from Vδ2 T cells using transwell inserts (n= 3).
*p<0.05, **p< 0.01 using a paired t -test, compared to BC alone (left
panels) or compared to B cell control (right panels) except where indicated
by horizontal lines.
proliferation but not IFN-γ, IL-2, IL-4, or IL-10 production. These
findings suggest that Vδ2 T cells can drive the differentiation of DC
into TH1-promoting APC and B cells into APC that can stimulate
different T cell responses.
Several studies have demonstrated a flexibility of DC matu-
ration and their ability to differentiate into APC that selectively
promote TH1, TH2, or tolerogenic T cell responses (30–33). The
factors that determine the fate of DC differentiation include the
nature of antigen and the presence of TLR ligands and cytokines
and it appears that Vγ9Vδ2 T cells contribute by driving TH1-
promoting APC generation. Tolerogenic APC are characterized
by the expression of MHC class II and co-stimulatory mole-
cules in the absence of pro-inflammatory cytokine production
and they can present antigen to T cells resulting in the induc-
tion of anergy or the expansion of regulatory T cells (30–33).
Our data suggest that Vδ2 T cell-matured B cells may function
as tolerogenic APC, since they display phenotypes of APC but
they do not produce pro-inflammatory cytokines and they stim-
ulate proliferation but not cytokine production by alloreactive T
cells. Furthermore, the ability of Vδ2-matured B cells to produce
the anti-inflammatory cytokine IL-4 further supports a tolero-
genic phenotype and we speculate that the IL-4 may function in
promoting antibody responses. This is supported by the study
by Caccamo (26), which showed that a subset of Vδ2 T cells
that produce IL-4 and IL-10 provide help to B cells for anti-
body production. B cells have previously been shown to present
antigen, resulting in tolerogenic T cell responses (34, 35), but
future work is required to determine if the T cells stimulated
by Vδ2-matured B cells have tolerogenic or immunosuppressive
activities.
Since the mechanisms underlying DC and B cell activation by
Vδ2 T cells are poorly understood, we aimed to identify the mole-
cules required to mediate these functional changes. We found that
while co-stimulatory molecules, pro-inflammatory cytokines and
physical contact with Vδ2 T cells were important for DC matu-
ration, co-stimulatory markers, and contact played only a minor
role in B cell maturation and were not important for antibody
production. Blocking CD40L and separating the B cells from Vδ2
T cells resulted in less upregulation of HLA-DR by B cells, but
did not significantly affect the other readouts. Our results are in
contrast to the study by Caccamo (26), which showed that IL-10,
IL-4, CD40L, and ICOS abrogated antibody production. However,
they did not investigate the role of these factors on co-stimulatory
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FIGURE 5 | Vδ2-matured DC and B cells stimulate proliferation of resting
allogeneicT cells. DC or B cells were co-cultured with HMB-PP-expanded
human Vδ2 T cells in the absence or presence of HMB-PP (denoted H). After
24 h CellTrace-labeled allogeneic resting αβT cells were added at a ratio of
10:1 and cultured for 6 days. (A) Representative dot plot showing proliferating
T cells. (B) Histogram showing proliferating T cells (green peaks) versus
unstimulated T cells (red peak) by flow cytometric analysis of cell trace
dilution. (C) Average (±SEM) percentage of proliferating T cells when cultured
with Vδ2-matured DC (n=10; left) and levels of IFN-γ and IL-4 secreted by
cultures of Vδ2 T cell matured DC with αβT cells (n= 6–10). (D) Average
(±SEM) percentage of proliferating T cells when cultured with Vδ2-matured B
cells (n= 4) and levels of IFN-γ and IL-4 secreted by cultures of Vδ2 T cell
matured DC with αβT cells (n= 4). *p< 0.05, **p<0.01, ***p<0.001, paired
t -test versus T cells except where indicated by horizontal lines.
marker expression and cytokine production by B cells. Thus, the
mechanisms responsible for B cell activation need to be further
elucidated.
The adjuvant effects of Vδ2 T cells display similarities to those
of other innate T cells. Invariant natural killer T (iNKT) cells,
so called because of their conserved TCR α-chains that recognize
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FIGURE 6 | Vδ2T cells have distinct adjuvant effects for DC and B
cells. Co-cultures of Vδ2 T cells with either DC or B cells produce IL-6
and TNF-α, but not IL-12 nor IL-10. However, Vδ2 T cells induce IFN-γ
production and co-stimulatory marker expression by DC after 24 h and
these matured DC induce proliferation of alloreactive T cells, which
then secrete IFN-γ. In contrast, Vδ2 T cells induce IL-4 production and
co-stimulatory molecule expression by B cells after 72 h and
immunoglobulin secretion after 7 days. These matured B cells induce
proliferation but not IFN-γ, IL-2, IL-4 nor IL-10 production by alloreactive
T cells.
glycolipid antigens presented by CD1d, can also induce matura-
tion of DC into APC (36–38) and B cells into antibody-secreting
plasma cells (39–42). Similar to Vδ2 T cells, iNKT cells induce
MHC and co-stimulatory molecule expression by both DC and
B cells, but they predominantly induce IL-12 production by DC
(36, 37, 43) and IL-4 and IL-10 production by B cells (44). Fur-
thermore, DC cultured with iNKT cells acquire phenotypes and
functions of immunogenic APCs, whereas B cells cultured with
iNKT cells differentiate into antibody-producing plasma cells but
they are inhibited in their ability to stimulate alloreactive T cell
proliferation (44). Other subsets of human γδ T cells also possess
adjuvant activities. T cells expressing the Vδ1 and Vδ3 TCRs can
promote maturation of DC into APCs capable of driving T cell
proliferation (45–47) and one study has shown that a population
of Vδ1+ T cells specific for pollen-derived antigens can drive IgE
production by B cells in vitro (48). Therefore, Vδ2 T cells belong to
a family of innate T cells that can differentially promote or regulate
T cell and antibody responses through selective interactions with
DC and B cells. Whereas Vδ2 T cells promote immunogenic TH1
responses by inducing maturation of DC into APCs, they appear
to promote T cell tolerance via their adjuvant activities on B cells,
while at the same time promoting antibody production (Figure 6).
While Vδ2 T cells are already under investigation as adjuvants for
immunotherapies in clinical trials for cancer (49–51), their dis-
tinct effects on DC and B cells must be considered in order to
prevent unwanted immunosuppression or autoimmunity.
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